博文

Can new direct-acting antiviral drugs cure hepatitis B virus infection?

日期：
0

Scott Friedman: Mechanisms of fibrosis progression and therapeutic targets

日期：
0

Does liver cancer monitoring still need to be carried out after hepatitis virus clearance?

日期：
0

Can the goal of eliminating viral hepatitis by 2030 be achieved?

日期：
0

AASLD 2020 | Prof. Jorge A. Bezerra: Turn challenges into opportunities! chronic disease management and scientific research in epidemic situation

日期：
0

AASLD 2020 |Prof. Raymond Chung: Development of new drugs for hepatitis B and NASH, and chronic disease management in epidemic situation in 2020

日期：
0

AASLD 2020 | Prof.Scott L. Friedman: Ten years of progress in hepatology, precision medicine brings great opportunities

日期：
0

AASLD2020 | Prof. Bjornsson E talking about the diagnosis and treatment of DILI——"Further exploration of strategies for the treatment of medically induced liver injury is very necessary"

日期：
0